Quest Diagnostics Incorporated (DGX) vs Guardant Health, Inc. (GH)
- Quest Diagnostics Incorporated DGX 235.00 −1.74%
- Guardant Health, Inc. GH 158.29 −4.58%
Quest Diagnostics Incorporated and Guardant Health, Inc. are both Diagnostics & Research companies. Quest Diagnostics Incorporated is the larger, with a market value of $26.4B against $22.3B — 1.2× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Quest Diagnostics Incorporated trades at 24.6×. Guardant Health, Inc. grew revenue faster over the last twelve months: 42.7% against 9.87%. Quest Diagnostics Incorporated has the higher net margin (9.15% vs −38.3%) and the higher return on invested capital (7.94% vs −129.7%). Across the 18 metrics below, Quest Diagnostics Incorporated leads on 10 and Guardant Health, Inc. on 8.
Valuation
Profitability
| Metric | DGX | GH | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.11% | 65.01% | 50.89% |
| Operating margin | 14.10% | (39.75%) | (8.57%) |
| Net margin | 9.15% | (38.33%) | (6.37%) |
| Free cash flow margin | 11.67% | (20.35%) | 0.00% |
| Return on equity | 14.03% | 171.64% | (2.92%) |
| Return on assets | 6.43% | (27.95%) | (6.71%) |
| Return on invested capital | 7.94% | (129.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack